brochure

LIFE SCIENCES LEADERSHIP
AND BUSINESS STRATEGIES
UNIVERSITY OF BASEL
ADVANCED STUDIES
STEINENGRABEN 21, 4051 BASEL
SWITZERLAND
MARCH 2 – 3, 2015
APRIL 15 – 16, 2015
Accredited by SwAPP/ SGPM
INVITATION
Leaders in the life sciences are regularly faced with difficult dilemmas and tough challenges. The
key to outstanding leadership is deep understanding and awareness of oneself, one’s colleagues,
one’s organisation, and one’s environment—coupled with the capacity to build relationships and
trust, vision and strategic thinking about drivers for change, and decisive action and crisis management.
Our Life Sciences Leadership and Business Strategies Course explores in theory and practice
what it takes to be an effective leader. Participants will get the core management skills which are
needed to fully leverage the human capital of their department or company. The course aims to
fill the gaps between leadership and management, vision and reality, strategy design and implementation in the Life Sciences / Health / Insurance Industries. Hence, science-minded managers
should be turned into capable business leaders.
We are looking forward to welcoming you to this course.
Prof. Dr. Thomas D. Szucs
Dr. Annette Mollet
Dr. Patricia Blank
Director ECPM
Head of Education & Training
Senior Research Scientist
COURSE OUTLINE
This course offers the basic principles of innovation leadership and gives insight
into legal and health economics, portfolio management, and regulatory and
financial basics in life science.
The course programme covers four days including presentations, company and
industry relevant interactive teaching with case studies, practical exercises and
short communication by participants.
LEARNING OUTCOMES
At the end of this module the student should be able to:
1.Understand basic principles of innovation leadership for profitable growth, results through speaking and listening, lead cross cultures, and communi­-
cation strategies,
2.Describe new tools and practices in bringing a new molecule to market,
3.Be capable to utilise basics of legal and health economics including
constraints of conducting a successful biopharmaceutical business,
4.Recognise evolving expectations from the regulatory and financial
environment,
5.Outline the basics in various types of alliances, valuation of technologies, portfolio management, joint ventures, partnerships, pricing of drugs,
6.Understand structuring successful collaborative arrangements between
pharmaceutical companies, SMEs and universities,
7.Appraise the role and key competences and tasks of a CEO, including
perspectives of an employee, a CEO and a board member.
TEACHING FACULTY
The teaching faculty consists of internationally and nationally renowned scientific
and consultancy managers from life science organisations, government and
academia.
MARCH 2 – 3, 2015
DAY 1
(SUBJECT TO CHANGE)
Trends and Future in Life Sciences Industries and the Crucial Role of
Management
Thomas D. Szucs, ECPM Basel
Otto Schwarz, Actelion Allschwil
Alexandra Goll, TVM Captial, Munich
•
•
•
•
Leading Knowledge Workers – on becoming a business leader
Issues and Perspectives in Pharmaceutical Research & Development
Improving Organizational Performance
Crisis management (types of crises, coping strategies, preventative measures)
Financial Management: Macroeconomics and Microeconomics
Capital Markets, Investments, Valuations Balances, and Economics
Martin Austin, TransformRx Basel
Chandra P. Leo, HBM Partners AG Zurich
• Leading the Innovation Process: The Investor’s Perspective
• Health Systems Economics and Trends in Health System Development:
Economics of Drug Development
DAY 2
The Role of a CEO and the Board
Thomas D. Szucs, ECPM Basel
Ulf Grawunder, CEO NBE-Therapeutics Basel
David Ebsworth, former CEO Vifor Pharma AG and Galenica Ltd
• Financial Management Control and the Physician’s Role and the Board
Member’s View
• Experiences and View of a CEO: Role, Key Competences and Tasks
of a Biotech/ SME
• Experiences and View of a CEO: Role, Key Competences and Tasks
of Big Pharma
• Panel discussion: Management Pearls of Wisdom
Leadership: Motivating Global Teams, Social Competence
Alex Khatuntsev, Actelion Allschwil
Cesar Escrig, Novartis Pharma AG Basel
Alexander Schuster, Mentavis Consulting London
•
•
•
•
The Principles of Leadership and Motivation
Leading High Performance Teams
Applied Change Management
Interactive Workshop “Organisational Change: Applied Change Management”
APRIL 15 – 16, 2015
DAY 3
(SUBJECT TO CHANGE)
Business Development: Portfolio Management and Market Access
Manfred Heinzer, Roche Pharma Schweiz Reinach
Valentina Sartori, McKinsey Zurich (invited)
Anthony Hörning, Consulant, Basel
Jorge Wernli, Vifor Glattbrugg
• Portfolio Management and Growth Strategies
• Pharma R&D and the Interface to Commercial: From Attrition Rates in the
Pipeline to Value-Driven Development Models
• Collaborations & Alliances
• Pricing and Market Access Performance: How to Speed up Market Access
and Optimize Pricing and Reimbursement Results?
Legal Responsibilities and Negotiation
Thomas D. Szucs, ECPM Basel
Xavier Luria, Senior Independent Consultant London
Judy Churchill, Language Consulting Services Ltd UK
• Health Care Management: Corporate Governance and Legal Responsibilities
for Reducing and Addressing Error
• Strategic Approaches to Worldwide Regulation and Reimbursement
• Negotiating and Communicating in a Multi-Cultural Environment
DAY 4
Life-Cycle Management, Intellectual Property, and Licensing
Hans Dettmers, LifeCycle Management Expert Basel
Eric Notegen, F. Hoffmann-La Roche AG Basel
Bertrand Lehuu, Aquapharm BioDiscovery Ltd. Edingburgh
• Strategic Life Cycle Management
• How to Protect Intellectual Property: Having the Vision to Make the Most
of Invisible Assets
• Elements of an Ideal Licensing Agreement: Effective Negotiation and Forming
Alliances Across Borders
ORGANISING INSTITUTION
ECPM, Institute of Pharmaceutical Medicine, University of Basel
Klingelbergstrasse 61, CH-4056 Basel, Switzerland
Phone +41 61 267 1950, Fax +41 61 267 1948
www.ecpm.ch or [email protected]
TITLE AND CREDIT POINTS
This course is an elective module of the Master in Medicines Development
(MMD) Programme but can also be booked as a stand-alone continuing
education course. Successful participation is awarded 3 ECTS.
COURSE FEE
• CHF 3’750.– standard course fee
• CHF 2’250.– for university employees and non for profit organisations
The fee includes meeting materials, lunch, coffee. After registration you will
receive an invoice. For short notice registration, please provide a copy of the
money transfer at the registration desk.
CANCELLATION
Fees will be refunded, after deduction of a 30% administrative charge, if cancellation is received in writing (by email, letter or fax) by February 23, 2015.
ECPM may transfer your registration to another member of your company.
In the unlikely event the course is cancelled, our liability is limited to refunding
workshop fees. Speakers are subject to change without notice.
COURSE VENUE
Advanced Studies, Steinengraben 22, 4051 Basel, Switzerland
From Basel Bahnhof SBB / Swiss Railway Station:
Take bus no 30 (leaving in front of Confiserie Bachmann, direction Badischer
Bahnhof) to „Steinenschanze“ (1 stop, 2 min).
From Basel Badischer Bahnhof / German Railway Station:
Take bus no 30 (direction Basel Bahnhof SBB) to „Steinenschanze“ (20 min).